PUCCF News 0.0220 Pancontinental Uranium Corporation (PUCCF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pancontinental Uranium Corporation (PUCCF) 0.0220 $PUCCF

BCSC Panel Issues Reciprocal Orders Against 18 Individuals
Marketwire Canada - Thu Jan 30, 3:30PM CST
A British Columbia Securities Commission panel has reciprocated enforcement orders against 18 individuals sanctioned by the Alberta Securities Commission, the New Brunswick Securities Commission, the Nova Scotia Securities Commission, the Ontario Securities Commission, and the Saskatchewan Financial Services Commission. They are:

Pancon's JV Partner, Crossland, Announces New Director / Substantial Investor with Rare Earth Experience
Marketwire - Wed Aug 07, 11:59AM CDT
Pancontinental Uranium Corporation (TSX VENTURE: PUC) ("Pancon" or the "Company" is pleased to announce that its JV partner, Crossland Strategic Metals Limited (ASX: CUX), has appointed Mr. Sia Hok Kiang to the Crossland Board. In addition to joining the Board Mr. Sia will make a common share investment in Crossland of approximately A$1.2 million in two tranches in August and September, 2013. The details of the investment were reported on August 6 in Crossland's ASX release. The investment will be through Mr. Sia's Malaysian Company, HK Rare Earths Sdn. Bhd.

IIROC Trading Resumption - PUC
CNW Group - Tue Apr 16, 6:53AM CDT
Trading resumes in:

Pancontinental Uranium Corporation: Charley Creek REE Project Scoping Study Delivers Robust Economics for a Long-Life, Low Capital Cost Project
Marketwire - Tue Apr 16, 5:31AM CDT
Pancontinental Uranium Corporation (TSX VENTURE: PUC) ("Pancon" or the "Company" is pleased to announce that its Joint Venture partner, Crossland Uranium Mines Limited (ASX: CUX) ("Crossland", issued two press releases Monday in Australia. Both are related to the publication of the JV's JORC-compliant Charley Creek REE Scoping Study. The first is an extensive summary and review of the Scoping Study and the second is their latest investor presentation on Charley Creek. Both are accessible through the links provided in this release.

IIROC Trading Halt - PUC
CNW Group - Mon Apr 15, 8:14AM CDT
The following issues have been halted by IIROC:

IIROC: Halt, Pancontinental Uranium Corp.
Marketwire Canada - Mon Apr 15, 8:10AM CDT
The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants :

Pancontinental Uranium Corporation: Scoping Study at Charley Creek REE Project Due at End of February
Marketwire Canada - Wed Jan 30, 5:30AM CST
Pancontinental Uranium Corporation (TSX VENTUREUC) ("Pancon" or the "Company" is pleased to report that today its Joint Venture partner, Crossland Uranium Mines Limited ("Crossland", announced that the Scoping Study for a mining and processing operation at the Charley Creek Alluvial Rare Earth Project in Central Australia is proceeding well.

Pancontinental Uranium Corporation: Crossland Appoints Dr. Tony Chamberlain as Chief Operating Officer to Advance the Charley Creek Project
Marketwire - Mon Jan 14, 10:41AM CST
Pancontinental Uranium Corporation (TSX VENTURE: PUC) ("Pancon" or the "Company" is pleased to announce that today its Joint Venture partner, Crossland Uranium Mines Limited ("Crossland", announced the appointment of Dr. Tony Chamberlain as Chief Operating Officer.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading